Digital wound measurement devices help in analyzing and facilitating the treatment of wounds in an efficient manner. These devices incorporate advanced technologies including digital planimetry, automated wound outline detection, and three-dimensional scanning for precisely measuring the dimensions of wounds, rate of healing, and depth of tissues. Products associated with this market include contact wound measuring devices and non-contact wound measuring devices.
The global digital wound measurement devices market is estimated to be valued at US$ 86.99 Mn in 2024 and is expected to exhibit a CAGR of 3.3% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
The rising application of telemedicine across the globe is expected to boost the demand for digital wound measurement devices. Telemedicine allows remote monitoring of chronic wounds and facilitates virtual consultation between healthcare providers and patients. This not only improves patient care but also reduces unnecessary visits to clinics and hospitals. Moreover, advanced 3D scanning and imaging capabilities of digital wound measurement devices help clinicians to accurately assess deep, complex, and hard-to-measure wounds from a distance, thereby supporting telehealth services.
Another key growth driver is the ability of these devices to generate real-time data on wound conditions and healing process. Detailed wound metrics collected with digital measurement enable healthcare providers to closely track wound progression, modify treatment plans, and assess the effectiveness of therapies. This data-driven wound management leads to better clinical outcomes.
Digital wound measurement devices market is segmented into contact and non-contact wound measurement devices. Contact wound measurement devices segment presently accounts for the major market share on account of higher accuracy provided by these devices as compared to non-contact devices. However, non-contact wound measurement devices segment is expected to witness fastest growth over the coming years owing to advantages such as its ability to measure wounds without direct contact and thereby reducing risk of infection.
Political: Government initiatives supporting adoption of advanced wound care devices is boosting market growth. However, stringent regulatory approvals are restraining commercialization of new products.
Economic: Rising healthcare spending coupled with growing incidence of chronic wounds worldwide is fueling demand for digital wound measurement devices. Currently high cost of advanced devices limits their use in cost-sensitive regions.
Social: Increasing patient awareness about benefits of precise wound measurement and management is prompting adoption of digital devices. However, lack of expertise especially in developing nations poses challenge.
Technological: Integration of technologies like artificial intelligence and internet of things in wound measurement devices is improving their accuracy and usability. Ongoing R&D efforts are also expanding application areas.
The Global Digital Wound Measurement Devices Market Size is expected to witness high growth over the forecast period of 2024 to 2031 driven by factors such as rising geriatric population prone to chronic wounds and increasing use of advanced wound care products. The global digital wound measurement devices market is estimated to be valued at US$ 86.99 Mn in 2024 and is expected to exhibit a CAGR of 3.3% over the forecast period 2024 to 2031.
The regional analysis also comprises North America is the dominant market for digital wound measurement devices currently and is expected to remain most lucrative during the forecast period as well due to favorable reimbursement and regulatory policies supporting adoption of advanced wound care devices in the region.
Key players operating in the digital wound measurement devices market are Aegis Medicals, Refine Medical Technology, Delta Medical International, Micro Lab, M&B, Dräger, Xuzhou Kejian Hi-tech and Natus Medical. Among these, Aegis Medicals and Refine Medical Technology account for major share on back of their comprehensive product portfolio and global presence.